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Objectives: The objective of this work is to compare the result of using topical
Mitomycin C in endoscopic dacryocystorhinostomy associated with probing and
bicanalicular silicon stenting in primary cases of epiphora due to post-saccal
obstruction.
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Background: Epiphora is a very troublesome symptom that may annoy the young
as well as the old in both sexes. The goal of endoscopic DCR is to re-establish
tear flow from the lacrimal sac into the nasal cavity through endonasal Approach.
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Patients and Methods: Forty patients complained of epiphora were included in
this study in the period from February 2015 to march 2017 . All were primary cases
and all of them were chronic dacryocystitis (post-saccal obstruction). Assessment
of epiphora was done both subjectively and objectively both preoperatively and
postoperatively utilizing both Jones 1 and Jones 11 tests. All cases were followed
up for at least one year and in some cases up to two years.
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Results: We find that the total success rate is (87.5%), with (90%) in group (A)
and (85%) in group (B) with insignificant use of topical Mitomycin C in endoscopic
endonasal DCR in cases of post-saccal obstruction.
Conclusion: Endoscopic endonasal dacryocystorhinostomy with probing and
bicanalicular silicon stent intubation is an effective treatment modality in the
management of epiphora due to post-saccal obstruction, but using topical
Mitomycin C has no benefit in such cases.
Keywords: lacrimal pathway, lacrimal system, lacrimal pathway obstruction,
Endonasal endoscopic dacryocystorhinostomy, mitomycin.
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Introduction
Epiphora or abnormal tearing is a medical problem causing
discomfort to the patient. It occurs as a result of blockage
in the lacrimal drainage system which impairs normal tear
channelling into the nose. As a result of lacrimal stagnation,
infection may also occur. The Dacryocystorhinostomy
operation, which involves fistulization of the lacrimal sac
into the nasal cavity, may alleviate the symptoms.It was first
described via an external approach by Toti in 1904. [1]
The first intranasal DCR was described by Caldwell in 1893.
[2] McDonogh and Meiring [3] described the endoscopic
transnasal DCR. Since this description a number of
modifications had been developed with good instrumentation
and also using different kinds of lasers such Holmium: Yag,
argon, carbon dioxide and also KTP laser. [4]
The endoscopic approach has several advantages;it provides
a better ethetic result with no external scar. It avoids injury
of medial canthus.It preserves the pumping mechanism of
orbicularis oculi muscle. [5]
The two most common causes of failure in DCR surgery
are closure of the surgically created osteotomy with soft
tissue obstruction at the common canaliculus. Many surgeon
elect to insert bicanalicular silicone stents at the time of
surgery. [6] While others prefer not to use them because of

concerns related to silicone tubing induced granulomatous
inflammation, which may compromise long term ostium
patency. [7] The success rates without using the stents
reaching up to 100%. [8]
Analyses of Boush et al series showed that majority of the
surgical failures occurred withen 4 months after endoscopic
surgery. Zilelioglu et al preferred to leave the siliastic tubes
for 4-6months after endoscopic surgery. The stent interval
proposed by different authors range from 4weeks to 24weeks.
[9] The longer duration of tube retention is associated with
higher chances of infection. The reported success rates with
intubation range from 70 to 100%. Antiproliferative agent
applied at the osteotomy site may reduce the fibrosis and
hence the failure rate. Mitomycin C (MMC) and 5-fluorouracil
have been equally successful in this regard. [10]
Dolmetsch [11] reported a success rate of 95% with
adjunctive use of MMC (0.5mg/ml for 10minutes) in a follow
up of 18.2 months in a non laser endoscopic endonasal DCR.
She also reported that intubation more than 3months was
associated with higher rates of obstruction.
In this prospective randomized study,we have two groups,
group (A) in which we use topical Mitomycin C and group (B)
done without Mitomycin C.
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The aim is to identify the role of Mitomycin C in endoscopic
endonasal DCR to correlate the efficasy of endoscopic DCR
with and without MMC.MMC has been used in different
concentrations and time by various authors such as 0.5 mg/
ml for 2.5, 5 and 10 minutes.Also 0.4mg/ml has been used
for 3 and 5 minutes. [12]
Patients and Methods
This prospective case control study started in February 2015
to march 2017 was conducted on forty cases, all of them
were selected from Ophthalmology and ORL Departments
of Menoufia University hospital after approval of ethical
committee of the hospital. A written consent was taken
from all patients and they were informed with the results
of the study. All of them were primary cases suffering from
epiphora due to nasolacrimal duct obstruction (post-saccal),
but revision cases and those with proximal obstruction,
severe maxillo-facial trauma, suspicious malignancy were
excluded from this study.All patients underwent endonasal
endoscopic dacryocystorhinostomy with application of silicon
tubes.
Patients were forty in number divided randomly into
two groups, group (A) and group (B), twenty patients for
each group. Group (A) patients were subjected to topical
Mitomycin C after surgery while group (B) not. Fifteen
females (37.5%) and twenty five males (62.5%) with a mean
age (35.6 plus or minus 22.67) . All cases were diagnosed as
chronic dacryocystitis (post-saccal obstruction).
Methods:
Preoperative preparation:
Preoperatively, all patients were subjected to detailed
history taking and general examination. Local examination
was done by Ophthalmologist including inspection (to
exclude lid patholoy), palpation of the lacrimal sac (in case
of dacryocystitis), nasal endoscopy (to examine the nasal
cavity). Jones 1 test (in which we put lacal anaesthetic eye
drops in the eye followed by putting fluorescein patches in
both conjunctival fornices and putting a piece of cottonoid
in each nostril in the inferior meatus it is considered negative
if the cottonoid does not take the stain of fluorescein dye
after 5 minutes) and Jones 11 test (in which a size 0 or 00
Bowman lacrimal probe is then put through the inferior or
superior canaliculus to palpate the common internal punctum
and also irrigation using 25 gouge blunt lacrimal canula in the
inferior punctum to test patency).
CT- scan axial and coronal cuts without contrast were
done to assess the nearby structures and also laboratory
investigations were done.
Operative procedure:
•
All the operations were done under general anaethesia
with hypotesive technique in Ophthalmology operative
theatre.
•
Haemostasis done by lacal application of 2% xylocain
with 1:10.000 adrenaline solution in acotton wads then
infiltration with the same solution with concentration of
1;100000.
•
Head of the patients were raised 30 degrees upwards
and turned to the right of the patient towards the
surgeon. A 4 mm, 0 or 30 degrees rigid endoscope was
introduced in to the nasal cavity and the whole nasal
cavity was visualized.
•
The 1.5×2 cm piece of mucosa anterior to the anterior
attachment of middle turbinate removed off
but
posteriorly based and corresponding lacrimal bone and
frontal process of maxilla were removed.
•
Probing (using bowman lacrimal probe) and dilatation
(using netel dilator) of the inferior and superior puncti

•
•

and canaliculi to the common canaliculus and then
toward the medial wall of the sac and tenting it.
The lacrimal sac then opened vertically using sickle knife
(as an open book),
Patency checked by saline irrigation ,then application of
0.5 Mitomycin C for 5 minutes in the osteotomy site in
half of patients group(A) then all patients were stented
and packed.

Postoperative follow up for 12 months:
•
The nasal pack was removed after 24 hours and stents
after 3 months.
•
Regular endoscopic assessment of the operation
regarding ostium size, presence or absence of
granulation tissue, adhesions or synechia with immediate
management of such cases.
•
All patients were assessed postoperatively subjectively
and objectively (flourescein test and irrigation test) in
Ophthalmology department as regard resolution of
epiphora after one month, after six months and at the
end of the first year.
•
The operation considered succeeded if the patient is
symptome free after twelve months of the operation.
Statistical analysis:
Data collected throughout history, basic clinical examination,
laboratory investigations and outcome measures coded,
entered and analyzed using Microsoft Excel software. Data
were then imported into Statistical Package for the Social
Sciences (SPSS version 20.0) (Statistical Package for the
Social Sciences) software for analysis.
According to the type of data qualitative represent as number
and percentage , quantitative continues group represent by
mean ± SD , the following tests were used to test differences
for significance;. Differences between frequencies (qualitative
variables) and percentages in groups were compared by Chisquare test.
Differences between parametric quantitative independent
groups by t test in non parametric by Man Whitney,. P value
was set at <0.05 for significant results &<0.001 for high
significant result.
Data were collected and submitted to statistical analysis. The
following statistical tests and parameters were used.
Results
Side distribution in group (A) were 12 right side and 8 left
side, in group (B) there were 9 right side and 11 left side ,all
cases were diagnonsed as chronic dacryocystitis (Table 1).
Additional surgeries were more or less similar in both groups
(no significant difference (Table 2).
Complication distribution in both groups nearly there is no
significant difference except granulation tissue formation at
ostium site which is more in group (B) than in group (A)
which gives slight benefit to the use of topical mitomycin C
(Table 3).
The succeeded cases were 19 in group (A) and 19 in group
(B) with success rate after one month was 95% in both
groups (Table 4).
After one year of follow up the Succeeded cases were 18 in
group (A) with success rate of (90%) and 17 cases in group
(B) with success rate (85%) so it is nearly the same success
rate in both groups with insignificant effect of Mitomycin C
(Table 5).
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Table 1 Characters among both groups
Mitomycin

Right

Group

Group

(A)

(B)

Total

Count

12

9

21

%

60.0%

45.0%

52.5%

Left

Count

8

11

19

%

40.0%

55.0%

47.5%

Chronic dacryocystitis

Count

20

20

39

%

100.0%

100%

100%

Count

0

0

Side

Diagn-osis

Trauma
Total

%

0.0%

0.0%

0.0%

Count

20

20

40

%

100.0%

100.0%

100.0%

X2

P

0.902

0.34

1.02

0.31

P value as regarding side on which we operate is 0.34.
p value as regarding diagnosis of cases 0.31

Table 2 Additional surgeries done in both groups
Mitomycin

No
Septoplasty
Additional
Turbinoplasty
Septoplasty + turbinoplasty +Fess
Total

Total

Group
(A)

Group
(B)

Count

10

9

19

%

50.0%

45.0%

47.5%

Count

2

2

4

%

10.0%

10.0%

10.0%

Count

5

6

11

%

25.0%

30.0%

27.5%

Count

3

3

6

%

15.0%

15.0%

15.0%

Count

20

20

40

%

100.0%

100.0%

100.0%

P value as regarding additional surgeries done with the main surgery is 0.98.

X2

P

0.14

0.98
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Table 3 Complication among groups
Mitomycin

No
Synaechia
Granulation
Skin abrasion
Complication
Stent loss
Orbital complication
Cheek swelling
Bleeding
Not
Complication
Complicated
Total

Group
(A)

Group
(B)

Total

Count

13

12

25

%

65.0%

60.0%

62.5%

Count

1

1

2

%

5.0%

5.0%

5.0%

Count

1

2

3

%

5.0%

10.0%

7.5%

Count

2

2

4

%

10.0%

10.0%

10.0%

Count

2

1

3

%

10.0%

5.0%

7.5%

Count

1

0

1

%

5.0%

0.0%

2.5%

Count

0

1

1

%

0.0%

5.0%

2.5%

Count

0

1

1

%

0.0%

5.0%

2.5%

Count

13

12

25

%

65.0%

60.0%

62.5%

Count

7

8

15

%

35.0%

40.0%

37.5%

Count

20

20

40

%

100.0%

100.0%

100.0%

X2

P

3.72

P1 0.81

0.107

P2 0.74

P1 value as regarding complications among cases is 0.81.
P2 value as regarding complicated and non complicated cases is 0.74.
Table 4 Follow up after one month among both groups
Mitomycin

Nosymptomes
Subjectively
Symptoms (epiphora)
+VE

Flourecein test
(objective test)

-VE
+VE

Regurge test
(objective test)

-VE
Total

Total

Group (A)

Group (B)

Count

19

19

38

%

95.0%

95.0%

95.0%

Count

1

1

2

%

5.0%

5.0%

5.0%

Count

19

19

38

%

95.0%

95.0%

95.0%

Count

1

1

2

%

5.0%

5.0%

5.0%

Count

1

1

2

%

5.0%

5.0%

5.0%

Count

19

19

38

%

95.0%

95.0%

95.0%

Count

20

20

40

%

100.0%

100.0%

100.0%

X2

P

-------

-------

-------

-------

-------

-------
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Table 5 Follow up after one year among both groups
Mitomycin
Group (B)

Count

18

17

35

%

90.0%

85.0%

87.5%

Symptoms

Count

2

3

5

(epiphora)

%

10.0%

15.0%

12.5%

Count

18

17

35

%

90.0%

85.0%

87.5%

Count

2

3

5

%

10.0%

15.0%

12.5%

Count

2

3

5

%

10.0%

15.0%

12.5%

Count

18

17

35

%

90.0%

85.0%

87.5%

Count

20

20

40

%

100.0%

100.0%

100.0%

No symptomes
Subjectively

Flourecein test
( objective test)

+VE
-VE
+VE

Regurge test
(objective test)

Total

Total

Group (A)

-VE

X2

P

0.22

0.63

0.22

0.63

0.22

0.63

P value as regarding post-operative follow up after one year is 0.63.

Fig 1 Skin abrasion, one of complication during drilling of
left lacrimal bone in a 2 years old male

Fig 2 Flourescein patches (Jones 1 test) in a 8 years
old male (primary case)
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Discussion
Dacryocystorhinostomy which had been performed in the
past hundred years is a surgical procedure by which lacrimal
flow is diverted into the nasal cavity through an artificial
opening made at the level of the lacrimal sac. The operation
can be carried out using either an external or endoscopic
endonasal approach. [12]
Tsirbas et al. [12] stated that the endoscopic approach has
several advantages over the external approach:
•

•
•
•
•

Fig 3 Jones 11(irrigation) test using blunt lacrimal
cannula in the right eye of the previous patient

It is less traumatic and there is no facial scar and no
dammage to angular vein or medial canthal tendon or
orbicularis oculi muscle and thus preserving lacrimal
pump function and avoiding double site dissection of
the lacrimal sac.
Additional surgeries can be done during the procedure
as septoplasty and FESS.
Relative disadvantages are:
Deep learning curve and massive surgical equibments
needed.
Relatively narrow field with relative risk of injury to
nearby structures like the eye.

In the present study we evaluate the topical effect of
antimetabolite agent namely Mitomycin C (MMC) as an
adjuvant therapy in cases of endoscopic endonasal DCR.
Complete relief from epiphora twelve months after surgery
as well as nasolacrimal patency confirmed by lacrimal
irrigation were the index for a satisfactory procedure. We
use the relief of symptoms as the measurement for success
of surgery. This meet the guidelines of the Royal college of
Ophthalmologists published in 1999. All of the patients had
preoperative diagnosis of the level of obstruction which was
done by the Ophthalmologist.
In our study, we operate on forty cases suffering from
epiphora they were divided randomely into two groups,
group (A) and group (B) , twenty patients for each group . In
both groups we did endoscopic endonasal DCR with topical
use of Mitomycin C in group (A) and without Mitomycin C
in group (B). Patients of two groups have insignificant age
difference with a mean age (35.6 year plus or minus 22.67).
The mean operative time in group (B) is about 42 minutes ,
and increased 5 minutes in group (A) and this matches with
(Hehar et al., 1997) who stated that excellent haemostasis
and easy access to the rhinostomy site were the main causes
for this short operative time.
Male patients are more than female patients (62.5% for
males and 37.5% for females). Right sided nasolacrimal
blockage occurs in 52.5% of patients while left sided occurs
in 47.5% of the patients. All patients were diagnosed as
chronic dacryocystitis in 40 cases (100%).
No additional procedure was needed in 19 cases (47.5%) ,
9 cases in group (A) and 10 cases in group (B). In 21 cases
(52.5%) we did additional procedure. Septoplasty were done
in 4 cases (10%), 2 in group (A) and 2 in group (B) , bilateral
inferior turbinoplasty were done in 11 cases (27.5%), 5 in
group (A) and 6 in group (B).
Combination of septoplasty, inferior turbinoplasty ,and
functional endoscopic sinus surgery were done in 6 cases
(15%), 3 in group (A) and 3 in group (B).

Fig 4 56 years old female patient one of primary
cases with EX-DCR on the left eye and EN-DCR on
the right eye (noting silicone tubes and minimal
skin abrasion at the vestibule)

Wormald [13] in forty seven endoscopic DCR procedures,
using powered instrumentation, had performed septoplasty
in 29% of patients.
Complications were absent in twenty five cases (62.5%) and
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present in fifteen cases (37.5%). Minimal skin abrasion of the
upper lip from bur occur in four cases (10%) two of them
in group (A) and two in group (B). Stent loss occurs in three
cases (7.5%) two of them in group (A) and one in group (B)
, in late cases we added a silk ligature over the sillicon stent
to prevent stent loss.Granulation tissue at the ostium site
occures in three cases (7.5%) one in group (A) and two in
group (B). Synaechia occurs in two cases ,one in each group.
Orbital complication (orbital fat exposure) occurs in one case
of group (A).Cheek swelling occurs in one case of group (B).
Bleeding (epistaxis) occur in one case of group (B). Skin
abrasion significantly happened in primary cases as there is
excessive use of electric bur to create a wide bony ostium at
the level of the lacrimal sac, during bony work trauma can be
happened from the shaft of the bur so care should be taken
during the use of electric bur in order to protect the upper lip
or the entrance of the vestibule specialy the collumella and
the most anteroinferior part of the nasal septum.
Wormald [13] reported exposure of orbital fat in one patient.
By analysis of the results of this study as regarding the
success rate we find the following:
•

•

Total success rate in both groups is (87.5%) as all
cases were diagnosed as chronic dacryocystitis (postsaccal obstruction) and they were all primay cases, the
reported success rate of EN-DCR using silicon tubes
vary from (82%-95%) according to Weidenbecher et al.,
(1994) Sprekelson and unlu (1996) Eloy et al., (1995)
unlu et al.,(2000) and thus similar to our study.
The effect of Mitomycin C on primary cases it seems
it has no effect , as the success rate in group (A) is
(90%) and (85%) in group (B), with only one case
difference in both groups and these results matching
with Zilelioglu et al.(9) who found that the success rate
of endoscopic DCR with intraoperative use of topical
Mitomycin C is (77.3%) where as without the use of
Mitomycin C was 77.8%. Hence there was no difference
between two groups regarding ostium size or success
rate. Farahani and Ramezani [14] conducted prospected
double blind randomized clinical trial and showed
that patient with nasolacrimal duct obstruction who
underwent endoscopic DCR did not benefit adjunctive
topical application of Mitomycin C. Although, clinically
there were lesser complications as regarding granulation
tissue formation with Mitomycin C group as compared to
control group but statistically they were not significant
as they were two cases in group (B) and only one case
in group (A).Our study not Matching with the result
of Apuhan et al. [15] and Selig et al., [16] both found
favourable effect of topical use Mitomycin C in primary
cases.As Mitomycin C has no role in primary cases of
endoscopic DCR and also is relatively expensive and
should be used within 2 weeks after preparation due to
its instability after this period,so its use in EN-DCR not
advised.

We can say that factors that determine or by another word
factors that enhance the success rate of EN-DCR should
include all of the following:
Wide bony ostium, complete marsipulization of the medial
wall of the lacrimal sac leaving the fundus and intensive postoperative care.
Conclusion
Endoscopic endonasal dacryocystorhinostomy with probing
and bicanalicular silicon stent intubation is an effective
treatment modality in the management of epiphora due to
post-saccal obstruction, but using topical Mitomycin C has
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no benefit in such cases. Future studies are needed to clarify
the role of EN-DCR in certain cases of pre-saccal obstruction
and the role of topical MMC in revision cases.
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